4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide
Product Details
- Product Name4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide
- CAS No.404844-11-7
- EINECS No.1312995-182-4
- MFC24H20ClN5O
- MW429.9
- AppearanceSolidPale Yellow to Light Beige
- density 1.329
- Melting point 300°C (dec)
- storage temp. Keep in dark place,Sealed in dry,Store in freezer, under -20°C
Cara563
▼
▲
▼
▲
4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide Basic information
▼
▲
Synonyms:
Imatinib impurity 18/4-(Chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide;N-[5[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]4-(3-pyridyl)-2-pyrimidine;4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide;N-[5-[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidineamine;IMatinib interMediate (N-[4-Methyl-3-(4-pyridin-3-yl-pyriMidin-2-ylaMino)-phenyl]-4-ChloroMethyl BenzaMide);4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide N-[5-[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidineamine;Imatinib genotoxic impurity D9
CAS:
MF:
C24H20ClN5O
MW:
429.9
EINECS:
1312995-182-4
Product Categories:
Mol File:
![4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide Structure](https://www.chemicalbook.com/CAS/GIF/404844-11-7.gif)
▼
▲
4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide Chemical Properties
▼
▲
Melting point
300°C (dec)
density
1.329
storage temp.
-20°C Freezer
pka
12.99±0.70(Predicted)
CAS DataBase Reference
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
-
VIP3年
- GLP Pharma Standards
- 404844-11-7 NLT 95%
- Inquiry
- 2026-04-02
-
VIP0年
- GLP Pharma Standards
- 404844-11-7 NLT 95%
- Inquiry
- 2026-04-02
-
VIP3年
- GLP Pharma Standards
- 404844-11-7 Imatinib Impurity NLT 95%
- Inquiry
- 2026-02-03
-
VIP0年
- GLP Pharma Standards
- 404844-11-7 Imatinib Impurity NLT 95%
- Inquiry
- 2026-02-03
-
VIP1年
- SYNTHENTA PVT LTD
- 1343476-44-7 97-99 %
- Inquiry
- 2026-06-11
-
VIP5年
- BTC pharm India
- 737789-87-6 Relugolix (1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea) 98+
- Inquiry
- 2026-03-18
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY
